Inactive Instrument

Company Canopy Rivers Inc Toronto S.E.

CA1380411084

RIV Capital Inc. is a Canada-based acquisition and investment company. The Company is focused on the United States (U.S.) cannabis market by acquiring, investing in, and developing operators and brands to create a multistate platform. The Company is a direct parent company of RIV Capital US Corporation and RIV Capital Corporation and exercises financial control over Etain, LLC. Through its strategic relationship with The Hawthorne Collective, Inc. (The Hawthorne Collective), a subsidiary of The ScottsMiracle-Gro Company (ScottsMiracle-Gro), the Company is The Hawthorne Collective's preferred vehicle for cannabis-related investments not under the purview of other ScottsMiracle-Gro subsidiaries. The Company's subsidiaries include 2683922 Ontario Inc., RIV Capital US Corporation, RIV Capital US Holdings LLC, RIV Capital US Real Estate LLC and RIV Capital US Services LLC.

Sales by Activity: Canopy Rivers Inc

Fiscal Period: March	2019 (CAD)	2020 (CAD)	2021 (CAD)	2022 (CAD)	2023 (USD)
U.S. Cannabis Platform	38.48M	12.19M	13.43M	1.9M	6.81M

See all business segments

Geographical breakdown of sales: Canopy Rivers Inc

Fiscal Period: March	2019 (CAD)	2020 (CAD)	2021 (CAD)	2022 (CAD)	2023 (USD)
United States	-	-	-	-	6.81M
Canada	38.48M	12.19M	13.43M	1.9M	-

See all geographic segments

Company details: Canopy Rivers Inc

RIV Capital, Inc.

40 King Street West

M5H 3Y2, Toronto

http://www.rivcapital.com/

Alternative Medicine

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
YUNNAN BAIYAO GROUP CO.,LTD	-1.01%	-2.64%	-15.59%	-9.93%	12.49B
BEIJING TONGRENTANG CO., LTD	-0.31%	-2.64%	-37.54%	-57.84%	4.62B
DONG-E-E-JIAO CO., LTD.	-1.35%	-4.27%	-16.34%	-7.35%	4.18B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-2.06%	+1.40%	+7.56%	-40.60%	3.82B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-2.58%	-2.35%	+11.46%	-17.26%	3.78B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-4.43%	-0.96%	-7.90%	-9.23%	3.64B
TASLY PHARMACEUTICAL GROUP CO., LTD	-1.67%	-3.62%	-13.56%	-3.82%	3.03B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.66%	-1.90%	-7.92%	-25.72%	2.34B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	-2.12%	-3.73%	-15.23%	+27.43%	1.64B
Average	-1.80%	-2.30%	-10.56%	-16.04%	4.39B
Weighted average by Cap.	-1.61%	-2.32%	-12.08%	-17.78%